IMMUNITYBIO, INC. (IBRX) Gross profit 2022–2025
IMMUNITYBIO, INC. (IBRX) annual gross profit history from SEC filings — each fiscal year as reported.
$112.5MFY2025 · since FY2022: $240,000 → $112.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $112.5M | +663.2% |
| FY2024 | $14.7M | +2270.6% |
| FY2023 | $622,000 | +159.2% |
| FY2022 | $240,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice